Courage Therapeutics
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
64 Homer St, Newton, Massachusetts, 0245...Phone Number
(617) 216-9921Website
www.couragetx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Courage Therapeutics
Courage Therapeutics is focused on developing innovative biological mechanisms aimed at achieving metabolic homeostasis. The company is creating therapeutic candidates that specifically target the MC4R and MC3R receptors. Their work is centered on leveraging the hypothalamus to address metabolic disorders. The intended clients include individuals seeking solutions for metabolic health issues.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Courage Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Courage Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Courage Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Courage Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Courage Therapeutics
Product Launch: Get notified when Courage Therapeutics launches new products
Click to see if Courage Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Courage Therapeutics recently announced quarterly report
Check if Courage Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Courage Therapeutics
Find 2 more new buyers
Compare Similar Companies to Courage Therapeutics
Compare insights from companies similar to Courage Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Courage Therapeutics
<$5M
1-10
Private
<$5M
2019
N/A
Company Profile Activity
Activity Insights
Courage Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Courage Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Courage Therapeutics.
Courage Therapeutics financials insights
Gather financial insights about Courage Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$1M
Courage Therapeutics Tech Stack
A closer look at the technologies used by Courage Therapeutics
Most Recent Scoops
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
Funding
Courage Therapeutics News & Media
Courage Therapeutics Appoints Biopharma Leader Giovanni Ferrara as CEO
ANN ARBOR, Mich.--(BUSINESS WIRE)--Courage Therapeutics, a company at the forefront of developing treatments for obesity and eating disorders, has appointed Giovanni Ferrara as its CEO.MC4R Agonist Drug Candidates Demonstrate Potential to Transform GLP1 Obesity Therapy
Courage Therapeutics announced new evidence of synergy between MC4R agonists and GLP1RA drugs in a paper published in the Journal of Clinical Investigation led by co-founder Dr. Roger Cone. The company has completed a drug discovery campaign to invent a best in class portfolio of MC4R agonists for obesity in order to leverage the synergy. Potential combinations with drugs such as Ozempic and Mounjaro could improve side [PR.com]Courage Therapeutics Awarded STTR Grant to Design Novel Anorexia Drugs
Courage Therapeutics has been awarded an STTR grant by the National Insittute of Mental Health to design novel anorexia drugs. The grant is a follow-up to research by the Cone lab at the University of Michigan that recently published in Science Translational Research that MC3R is a potential target for therapeutic development in anorexia and obesity. The effort allows for an expeditious translation of basic science into [PR.com]Courage Therapeutics Raises $1M for Treatment of Anorexia Nervosa and Other Related Eating Disorders
Courage Therapeutics raised $1M towards development of treatments for eating disorders including Anorexia Nervosa, ARFID, BED and genetic obesity. The company is led by Dan Housman a parent of children with eating disorders. The round was led by Michigan Biomedical Ventures. Funding will be used to test Courage’s proprietary compounds in animal models of eating disorders. The technology is based on the research on MC3R [PR.com]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Courage Therapeutics
Sign Up For FreeTo access detailed company insights
Courage Therapeutics is focused on developing innovative biological mechanisms aimed at achieving metabolic homeostasis. The company is creating therapeutic candidates that specifically target the MC4R and MC3R receptors. Their work is centered on leveraging the hypothalamus to address metabolic disorders. The intended clients include individuals s... Read More
